Table 2. Patient characteristics for Follow-up Study.
| Study eye | Age (years) | Sex | HbA1C (%) (entry/final) | Type of diabetes (1/2) | Length of diabetes (years) | PDR grade mild-1 moderate-2 severe-3 | Follow-up (mths) | |
|---|---|---|---|---|---|---|---|---|
| 1 | 29 | M | 8.5 | 7.8 | 1 | 29 | 2 | 24 |
| 2 | 29 | M | 8.5 | 7.8 | 1 | 29 | 2 | 24 |
| 3 | 59 | M | 7.5 | 6.4 | 2 | 3 | 2 | 24 |
| 4 | 48 | M | 8 | 8.3 | 2 | 17 | 1 | 24 |
| 5 | 42 | M | 7 | 6.7 | 1 | 30 | 2 | 24 |
| 6 | 42 | M | 7 | 6.7 | 1 | 30 | 2 | 24 |
| 7 | 49 | M | 6.3 | 7.1 | 2 | 8 | 3 | 18 |
| 8 | 49 | M | 6.3 | 7.1 | 2 | 8 | 2 | 18 |
| 9 | 37 | M | 10 | 7.8 | 1 | 18 | 3 | 23 |
| 10 | 37 | M | 10 | 7.8 | 1 | 18 | 3 | 23 |
| 11 | 35 | F | 7.4 | 6.3 | 1 | 23 | 2 | 21 |
| 12 | 53 | M | 7.2 | 9.1 | 2 | 20 | 2 | 22 |
| 13 | 53 | M | 7.2 | 9.1 | 2 | 20 | 2 | 22 |
| 14 | 34 | F | 7 | 7.6 | 1 | 26 | 1 | 20 |
| 15 | 34 | F | 7 | 7.6 | 1 | 26 | 2 | 21 |
| 16 | 34 | M | 9.2 | 8.1 | 1 | 26 | 2 | 6 |
| 17 | 34 | M | 9.2 | 8.1 | 1 | 26 | 1 | 6 |
| 18 | 59 | F | 9.5 | 10.4 | 2 | 30 | 2 | 18 |
| 19 | 52 | M | 5.5 | 6.2 | 1 | 10 | 2 | 22 |
| 20 | 29 | M | 5.5 | 6.2 | 1 | 10 | 2 | 22 |
| 21 | 53 | F | 7 | 5.6 | 1 | 47 | 2 | 20 |
| 22 | 51 | M | 9 | 9.2 | 1 | 22 | 3 | 20 |
| 23 | 51 | M | 9 | 9.2 | 1 | 22 | 3 | 21 |
| 24 | 30 | M | 8.1 | 6 | 1 | 10 | 2 | 17 |
| 25 | 34 | M | 8 | 8 | 1 | 1 | 2 | 18 |
| 26 | 44 | F | 6 | 6.5 | 1 | 28 | 2 | 15 |
| 27 | 44 | F | 6 | 6.5 | 1 | 28 | 2 | 15 |
| 28 | 49 | M | 8.8 | 7 | 1 | 30 | 1 | 15 |
| 29 | 49 | M | 8.8 | 7 | 1 | 30 | 1 | 15 |
| 30 | 48 | F | 8.9 | 7.5 | 2 | 1 | 2 | 12 |
| 31 | 48 | F | 8.9 | 7.5 | 2 | 1 | 1 | 12 |
| 32 | 51 | M | 9 | 8.2 | 2 | 5 | 3 | 15 |
| 33 | 51 | M | 9 | 8.2 | 2 | 5 | 3 | 15 |
| 34 | 35 | M | 9.2 | 7.2 | 1 | 30 | 1 | 15 |
| 35 | 35 | M | 9.2 | 7.2 | 1 | 30 | 1 | 15 |
| 36 | 70 | M | 6 | 6 | 2 | 11 | 2 | 12 |
Abbreviations: HbA1C, glycosylated haemoglobin; PDR grade, proliferative diabetic retinopathy; Mild PDR, neovascularisation elsewhere (NVE) or at the disc (NVD) less than standard Airlie House photograph 10A (SAH10A); Moderate PDR, NVE greater than half disc diameter (DD) and/or NVD greater than SAH10A; Severe PDR, multiple NVE greater than half DD, and/or forward NVD, and/or preretinal haemorrhage, and/or vitreous haemorrhage.